BioSpace News Archive

Clinical laboratory tests refer to various medical tests performed in a laboratory to gain information about the health condition of a patient by using their blood or urine samples.

Reports and Data has published its latest report titled Diabetes Devices Market By Type (Blood Glucose Monitoring Systems, Lancets, Test Strips or Test Papers, Insulin Delivery Devices, Diabetes Management Mobile Applications), By Distribution Channels, By End-use, and By Region Forecast to 2028.”

Increasing number of crimes of illicit activities across the globe, rising demand for advanced technologies for solving crimes, and high focus on developing and launching novel products are expected to drive global Forensic Technology market growth.

Paragonix Technologies, Inc., a leading organ preservation provider, announced expanded adoption of their LIVERguard Donor Liver Preservation System at the 2022 American Transplant Congress in Boston, Massachusetts.

Increasing prevalence of infectious diseases across the globe, rising need for effective vaccination against coronavirus, and growing investments for development of novel vaccines are some key factors expected to drive global Vaccine market.

The DMT Study is being conducted in the Netherlands at the Centre for Human Drug Research, a leading independent foundation specializing in innovative early-stage clinical drug research, in 50 healthy volunteers who smoke (cigarettes/nicotine users).

L7 Informatics, a leader in software for life sciences that delivers a flexible end-to-end platform for precision healthcare, today announced a $38 million investment led by Banneker Partners with participation from its pre-existing investors.

Nonagen Bioscience, a cancer diagnostics company, announced that Wayne Hogrefe, PhD, has been named COO.

Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder), a novel investigational therapeutic product candidate for the acute treatment of migraine, today announced that it will host a Key Opinion Leader (KOL) webinar on the acute treatment of migraine, DHE, and STS101 on Thursday, June 16, 2022 at 10:30 a.m. ET.

Nevro Corp. (NYSE: NVRO), today announced the results from data presentations at the American Diabetes Association (ADA) 82nd Scientific Sessions supporting the use of 10 kHz spinal cord stimulation (SCS) therapy for patients with chronic pain, including results from the SENZA Painful Diabetic Neuropathy (PDN) randomized controlled trial (RCT). Results were presented on Sunday, June 5, 2022.